US2870143A - Process for conversion of steroidal sapogenins to pseudosapogenins - Google Patents

Process for conversion of steroidal sapogenins to pseudosapogenins Download PDF

Info

Publication number
US2870143A
US2870143A US710588A US71058858A US2870143A US 2870143 A US2870143 A US 2870143A US 710588 A US710588 A US 710588A US 71058858 A US71058858 A US 71058858A US 2870143 A US2870143 A US 2870143A
Authority
US
United States
Prior art keywords
sapogenin
conversion
pseudosapogenins
pseudosapogenin
sapogenins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US710588A
Inventor
Monroe E Wall
Serota Samuel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US710588A priority Critical patent/US2870143A/en
Application granted granted Critical
Publication of US2870143A publication Critical patent/US2870143A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Definitions

  • This invention relates to an improved process for the conversion of steroidal sapogenins to their respective pseudosapogenins, relating particularly to performing the isomeriaation reaction under milder conditions .yet with greatly improved yields.
  • the isomerization of steroidal sapogenins to pseudosapogenins is a key step in the process ofc onvertiug such sapogenins to usefulsteroidal hormones.
  • This isomerization is ordinarily accomplished by. heating the sapogenin with acetic anhydride at 200 C. for hours in sealed Carius tubes or in pressure autoclaves. Itlhas been reported that poor results are obtained if the reaction is conducted at temperatures below 2 Q0 C Hence, in the present state of the art the. conversion ofsteroidal sapogenins to pseudosapo-genins "requires. .s pecial equipment for performing the reaction at highpre'ssures fyet the yields of pseudosapogenins are often poor, especially for certain specific pseudosapogenins, because of the high temperatures involved.
  • the isomerization reagent is also an effective acylatio-n agent.
  • the first product of the process for making pseudosapogenins are the pseudosapogenin 3,26-diacetates. These diacetates are oily and are rarely isolated.
  • the free pseudosapogenin is obtained in quantitative yield upon alkaline hydrolysis of the pseudosapogenin diacetate.
  • the critical feature in determining the yield of pseudosapogenin recovered is the result of the isomerization reaction. Hence, in subsequent discussions we have sometimes assumed the saponific-ation step to be included and used the terms isomerizaltion and conversion of sapogenin to pseudosapogenin synonymously.
  • An object of this invention is to provide an isomerization reagent which operates effectively at temperatures under 200 C. and at pressures less than about 45 p. s. i. g.
  • Another object is to provide an isomeriza-tion process which requires no special high pressure equipment.
  • a further object of this invention is to provide a process in which the isomerization of steroidal sapogenins is performed in consistently high yields regardless of the particular sapogenin being converted to pseudosapogenin.
  • an iso-merization reagent consisting of acetic anhydride containing a small amount of acetic acid converts steroidal sapogenins to their respective pseudosapogenins in high yields at reaction temperatures as low as 160 C. At such temperatures special equip ment is not required, the reaction being carried out in ordinary stoppered glass flasks. Conducting the reaction at these temperatures also leads to markedly improved yields of pseudosapogenins, the reaction proceeding almost quantitatively.
  • sapogenins are converted to their respective pseudos-apogenins 'by a process comprising heating the sapogenin in acetic anhydride containing a small amount, preferably about 0.1 to 1% volume to volume basis, of acetic acid at temperatures below 200 C., preferably at about 170-180 C., until the isomerization is substantially complete, hydrolyzing the resulting pseudosapogenin diacetate to pseudosapogenin, and recovering the pseudosapogenin.
  • the quantity of acetic acid added to the acetic anhydride can also be varied to give concentrations lower than and substantially higher than the preferred concentration of about 0:1 to 1% by volume Without aifec'ting significantly the improvement of the present invention.
  • acetic anhydride-acetic acid reagent is eiiective in converting sapogenins to pseudosapogenins over a temperature range of to 200 C., temperatures of about to 180 C. are preferred. At these temperaturcs the reactions can be performed in stoppered glass flasks, the rate of yields of pseudosapogenin are high.
  • EXAMPLE 3 Conversion of diosgenin to pseudodiosgenin
  • the procedure of Example 1 was followed. Isomerization in acetic anhydride containing 0.1% acetic acid was conducted at 180 C. for 10 hours. From 10 grams of diosgenin there was obtained 9.0 grams of pseudodiosgenin, M. P. 157-167 C.
  • EXAMPLE 4 Conversion of tigogenin to pseudotigogenin Tigogenin, 10.0 grams, was heated at 160 C. for hours in 25 ml. acetic anhydride containing 0.1% acetic acid. Following the procedures of Example 1, 7.8 grams of pseudotigogenin, M. P. 170-180 C., was recovered.
  • EXAMPLE 5 7 Conversion of hecogem'n to pseudohecogenin Using the isomerization conditions of Example 4, from 10.0 grams of hecogenin there was recovered 9.1 grams of pseudohecogenin, M. P. 189-195 C.
  • a process for converting a steroidal sapogenin to its psendosapogenin comprising heating said sapogenin in acetic anhydride containing about 0.1 to 1.0% by volume of acetic acid, at temperatures in the range of about to C., until the isomcrization of the sapogenin to its pseudo form is substantially complete.

Description

United States arm PROCESS FOR CONVERSION OF STEROIDAL SAPOGENINS TO PSEUDOSAPOGENINS Monroe E. Wall, Oreland, andSamuel Serota, Philadelphia, Pa assignors to the United States of America .as representedby the Secretary ofAgriculture No Drawing. Application Janpary QZ, 1958 Serial No. 710,588
Anon-exclusive, irrevocableroyalty-free license in the invention herein described, throughout the world forall purposes oi the United States Government,.with the power to grant sublicenses for such purposes, is hereby granted to .the Government of the United States of America.
This invention relates to an improved process for the conversion of steroidal sapogenins to their respective pseudosapogenins, relating particularly to performing the isomeriaation reaction under milder conditions .yet with greatly improved yields. j
The isomerization of steroidal sapogenins to pseudosapogenins is a key step in the process ofc onvertiug such sapogenins to usefulsteroidal hormones. This isomerization is ordinarily accomplished by. heating the sapogenin with acetic anhydride at 200 C. for hours in sealed Carius tubes or in pressure autoclaves. Itlhas been reported that poor results are obtained if the reaction is conducted at temperatures below 2 Q0 C Hence, in the present state of the art the. conversion ofsteroidal sapogenins to pseudosapo-genins "requires. .s pecial equipment for performing the reaction at highpre'ssures fyet the yields of pseudosapogenins are often poor, especially for certain specific pseudosapogenins, because of the high temperatures involved.
The isomerization reagent is also an effective acylatio-n agent. In actual practice the first product of the process for making pseudosapogenins are the pseudosapogenin 3,26-diacetates. These diacetates are oily and are rarely isolated. The free pseudosapogenin is obtained in quantitative yield upon alkaline hydrolysis of the pseudosapogenin diacetate. The critical feature in determining the yield of pseudosapogenin recovered is the result of the isomerization reaction. Hence, in subsequent discussions we have sometimes assumed the saponific-ation step to be included and used the terms isomerizaltion and conversion of sapogenin to pseudosapogenin synonymously.
An object of this invention is to provide an isomerization reagent which operates effectively at temperatures under 200 C. and at pressures less than about 45 p. s. i. g.
Another object is to provide an isomeriza-tion process which requires no special high pressure equipment.
A further object of this invention is to provide a process in which the isomerization of steroidal sapogenins is performed in consistently high yields regardless of the particular sapogenin being converted to pseudosapogenin.
We have discovered that an iso-merization reagent consisting of acetic anhydride containing a small amount of acetic acid converts steroidal sapogenins to their respective pseudosapogenins in high yields at reaction temperatures as low as 160 C. At such temperatures special equip ment is not required, the reaction being carried out in ordinary stoppered glass flasks. Conducting the reaction at these temperatures also leads to markedly improved yields of pseudosapogenins, the reaction proceeding almost quantitatively.
Even more surprisingly, we have found that the rate of conversion of individual steroidal sapogenins to their corresponding pseudosapogenin is markedly affected by yields .of the pseudosapogenins.
isolsapogenins, the normal isomer. is
r. 2,870,143 r Patented J an. 20, 1.959
2 the structure .of the parent .sapogenin and that heating beyond the point of complete conversion gives lower In particular, dilferences in the .spiroketal side chain configuration of sapogenins isgone factorwhich-leads to significant diiferences in the rate of conversion of the sapogenin to pseudosapogenin. In the accomp nying table (Table I) each pair of sapogenins is identical except for isomerism in the spiroketalside chain. The site of isomerism, now considered to be at C (cf. M. E. WallfExperientia 11, 340 (195.5), for areview of. pertinent literature), is.;immaterial to the presentinvention. The significance of the data in Table .I is that ineach pair of normal and converted to its respective pseudosapogenin muchmore rapidly than is the iso analogue.
TABLE L-OONVERSION 011 NATURAL SAPOGENINS 'IO PSEUDOSAPOGENINS VVITH AGETIC ANHYDRIDE-ACET- IO ACID AT 170 Sapogenin Side Chain A/B Ring Conversion isomerism Fusion Iimc, hrs.
Sarsasapogeninu NormaL..- -2 Smilagenin Iso 6 Ne0tigogenin. Normal .5 Tigogenin o 21 Yamogenin Normal A 7 Diosgenin Iso 22 :6 can alsojlalfect therate of I "to '-pseudosapogenin. The data of Table -I illustratet lI is l Nomenclature consistent with that given in Natural Products Relatedto Phenanthrenefl; 3rd ed,Eieserand Fi s rmt 5 7 1 Time req'uired for about or more of isomerization.
. 2 We havekalso foundthat 'diflerences inconfiguration at conversion 7 ofsapogenin influenceiis in thelorderof C cis C trans 'CA According to the present invention sapogenins are converted to their respective pseudos-apogenins 'by a process comprising heating the sapogenin in acetic anhydride containing a small amount, preferably about 0.1 to 1% volume to volume basis, of acetic acid at temperatures below 200 C., preferably at about 170-180 C., until the isomerization is substantially complete, hydrolyzing the resulting pseudosapogenin diacetate to pseudosapogenin, and recovering the pseudosapogenin.
Although we usually use a ratio of 2.5 parts of acetic anhydride containing acetic acid to one part of sapogenin, this ratio is not critical to the practice of the invention. Both higher and lower ratios of acetic anhydride-acetic acid to sapogenin have been used successfully.
The quantity of acetic acid added to the acetic anhydride can also be varied to give concentrations lower than and substantially higher than the preferred concentration of about 0:1 to 1% by volume Without aifec'ting significantly the improvement of the present invention.
While the acetic anhydride-acetic acid reagent is eiiective in converting sapogenins to pseudosapogenins over a temperature range of to 200 C., temperatures of about to 180 C. are preferred. At these temperaturcs the reactions can be performed in stoppered glass flasks, the rate of yields of pseudosapogenin are high.
The following examples are presented in illustration of the present invention.
EXAMPLE 1 Conversion of sarsasapogenin to pseudosarsasapogenin of acetic anisomerization is satisfactory, and the.
residue saponified by refluxing in 200 ml. of methanol containing 20.0 grams of potassium hydroxide. On dilu- EXAMPLE 2 Conversion of smilagenin to pseudosmilagenin Smilagenin. 10.0 grams, was heated 6 hours at 170 C. with 25 m1. of acetic anhydride containing 0.1% acetic acid. Following the procedures described in Example 1, pseudosmilagcnin was recovered. Recrystallization from ethyl acetate gave 8.8 grams of pseudosmilagcm'n, M. P. 161-162 C.
EXAMPLE 3 Conversion of diosgenin to pseudodiosgenin In general, the procedure of Example 1 was followed. Isomerization in acetic anhydride containing 0.1% acetic acid was conducted at 180 C. for 10 hours. From 10 grams of diosgenin there was obtained 9.0 grams of pseudodiosgenin, M. P. 157-167 C.
EXAMPLE 4 Conversion of tigogenin to pseudotigogenin Tigogenin, 10.0 grams, was heated at 160 C. for hours in 25 ml. acetic anhydride containing 0.1% acetic acid. Following the procedures of Example 1, 7.8 grams of pseudotigogenin, M. P. 170-180 C., was recovered.
' 1 l-oxo-diosgenin.
EXAMPLE 5 7 Conversion of hecogem'n to pseudohecogenin Using the isomerization conditions of Example 4, from 10.0 grams of hecogenin there was recovered 9.1 grams of pseudohecogenin, M. P. 189-195 C.
EXAMPLE 6 Using procedures similar to those of preceding examples, ll-oxo-tigogenin and ll-oxo-diosgenin were converted to their pseudo analogues. Identification verified by comparison of infrared spectra with those of authentic pseudo compounds.
We claim:
1. A process for converting a steroidal sapogenin to its psendosapogenin comprising heating said sapogenin in acetic anhydride containing about 0.1 to 1.0% by volume of acetic acid, at temperatures in the range of about to C., until the isomcrization of the sapogenin to its pseudo form is substantially complete.
2. The process of claim 1 in which the sapogenin is sarsasapogenin.
3. The process of claim 1 smilagenin.
4. The process of claim 1 diosgenin.
5. The process of hecogenin.
6. The process of claim 1 tigogenin.
7. The process of claim 1 1 l-oxo-tigogenin.
8. The process of claim 1 in which the sapogenin is in which the sapogenin is claim 1 in which the sapogenin is in which the'sapogenin is in which the sapogenin is in which the sapoge nin is References Cited in the tile or this patent Marker: I. A. C. S. September 1947, pages 2170, 2184, 2191, 2194, 2196.. V

Claims (1)

1. A PROCESS FOR CONVERTING A STEROIDAL SAPOGENIN TO ITS PSEUDOSAPOGENIN COMPRISING HEATING SAID SAPOGENIN IN ACETIC ANHYDRIDE CONTAINING ABOUT 0.1 TO 1.0% BY VOLUME OF ACETIC ACID, AT TEMPERATURES IN THE RANGE OF ABOUT 160 TO 180* C., UNTIL THE ISOMERIZATION OF THE SAPOGENIN TO ITS PSEUDO FORM IS SUBSTANTIALLY COMPLETE.
US710588A 1958-01-22 1958-01-22 Process for conversion of steroidal sapogenins to pseudosapogenins Expired - Lifetime US2870143A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US710588A US2870143A (en) 1958-01-22 1958-01-22 Process for conversion of steroidal sapogenins to pseudosapogenins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US710588A US2870143A (en) 1958-01-22 1958-01-22 Process for conversion of steroidal sapogenins to pseudosapogenins

Publications (1)

Publication Number Publication Date
US2870143A true US2870143A (en) 1959-01-20

Family

ID=24854660

Family Applications (1)

Application Number Title Priority Date Filing Date
US710588A Expired - Lifetime US2870143A (en) 1958-01-22 1958-01-22 Process for conversion of steroidal sapogenins to pseudosapogenins

Country Status (1)

Country Link
US (1) US2870143A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3005817A (en) * 1956-04-05 1961-10-24 Olin Mathieson 12alpha-halo-delta20(22)-furostene-3beta, 26-diol-11-one 3, 26-diacylate and preparation thereof
US20050113316A1 (en) * 2001-07-24 2005-05-26 Panagin Pharmaceuticals Inc. Process for producing dammarane sapogenins and ginsenosides

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3005817A (en) * 1956-04-05 1961-10-24 Olin Mathieson 12alpha-halo-delta20(22)-furostene-3beta, 26-diol-11-one 3, 26-diacylate and preparation thereof
US20050113316A1 (en) * 2001-07-24 2005-05-26 Panagin Pharmaceuticals Inc. Process for producing dammarane sapogenins and ginsenosides

Similar Documents

Publication Publication Date Title
US2870143A (en) Process for conversion of steroidal sapogenins to pseudosapogenins
US2959586A (en) 11, 18-epoxy steroid compounds
US2861086A (en) 17-oxygenated estra-1, 3, 5(10)-triene-1, 3-diols, and the corresponding esters and ethers
US3438975A (en) 15alpha,16alpha-methylene pregnanes and 19-nor-pregnanes
DE3024008C2 (en) Process for the preparation of 17α-hydroxy-ethiocarboxylic acids
US3716530A (en) Halogenation of steroids
US2716125A (en) 3(beta)-acetoxy-16(delta-acetoxyisocaprooxy)-allopregnanedione-11, 20
US2837515A (en) Halogenation process for converting delta7-allosteroids to delta 7, 9 (11)-allosteroi
US2716116A (en) Synthesis of sapogenin derivatives
US3299106A (en) Process for the preparation of uncontaminated 17alpha-ethynyl-19-nor-delta4-androsten-17beta-ol-3-one
US2531688A (en) Preparation of esters of 7-halogeno-cholesterol
US2395232A (en) Process for producing sterol derivatives
US2863886A (en) Process for the production 17alpha-ethinyl derivatives of androstane series of compounds
CA1138428A (en) PROCESS FOR PRODUCING .alpha.,.beta.-UNSATURATED ALDEHYDES AND KETONES
US2885411A (en) Process for the conversion of steroidal
US3164616A (en) Process for preparing delta11-steroid compounds
US2956052A (en) 5alpha, 6beta-dichloro-16, 17alpha-epoxyallopregnanes
US3054809A (en) 1-cyano-androstanes
US2779774A (en) 3beta-oxy-delta16-allopregnenedione-11, 20 and process
US2599007A (en) 21-halocholadienes
US2971964A (en) Preparation of 11alpha-hydroxy progesterone
US3753980A (en) Process for the preparation of 14-anhydrobufaline
US2894000A (en) 2, 4b-dimethyl-1-acetaldehydo-2-(beta-ketopropyl)-1, 2, 3, 4, 4a, 4b, 5, 6, 7, 9, 10, 10a- dodecahydrophenanthrene-4, 7-dione and methods of preparing the same
US2715637A (en) Process for producing detla4-3-ketosteroids and intermediates thereof
US3033872A (en) Method of making a substituted pregnadiene-dione